GlaxoSmithKline CEO Continues Restructuring With Job Cuts in Africa Post author:Sam Post published:January 17, 2018 Post category:BioPharma This Latest move is a wide-ranging effort to boost competitiveness. Source: BioSpace You Might Also Like Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017 Real Estate Developers Eye Boston’s South End for Life Science Campus November 13, 2017 Celgene Takes a $411M Hit From Discontinuation of Crohn's Disease Trials December 28, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
